## Clinical Overview Atherosclerotic heart disease (ASHD) of a native coronary artery without angina pectoris, represented by the ICD-10 code I25.10, is a major manifestation of chronic ischemic heart disease. This diagnosis is increasingly common in an aging population with high rates of metabolic risk factors. It describes a scenario where clinical evidence of significant coronary atherosclerosis exists—such as findings from coronary angiography, CT calcium scoring, or stress testing—but the patient is currently free from the hallmark symptom of angina pectoris (chest pain). This 'silent' presentation is particularly concerning because the first clinical manifestation for these patients can often be an acute myocardial infarction or sudden cardiac death. ### Pathophysiology The foundational process is the development of atherosclerotic plaques within the intima of the native coronary arteries. This process begins with endothelial injury, often triggered by long-term exposure to risk factors like hypertension, cigarette smoke toxins, or elevated levels of low-density lipoprotein (LDL) cholesterol. Following the injury, the endothelium becomes permeable, allowing lipids and inflammatory cells to infiltrate the subendothelial space. Macrophages ingest oxidized lipids to form foam cells, creating a fatty streak. Over time, smooth muscle cells migrate to the area, secreting extracellular matrix to form a fibrous cap over a lipid-rich core. In the context of I25.10, these lesions may be hemodynamically significant, yet the patient’s lifestyle or physiological compensation (such as collateral circulation) may prevent the occurrence of symptomatic angina. ### Clinical Presentation and Silent Ischemia Patients are typically identified during routine medical examinations or through screening for other conditions. A significant subset of these patients may have 'silent ischemia,' where objective evidence of myocardial ischemia is present during stress testing (e.g., ST-segment depression) without the patient feeling any pain. This phenomenon is frequently seen in individuals with diabetes mellitus due to autonomic neuropathy, which impairs the transmission of cardiac pain signals. Additionally, older adults or women may present with 'angina equivalents' such as atypical fatigue, indigestion, or exertional dyspnea, rather than classic pressure-like chest pain. ### Diagnostic Evaluation Diagnosis involves a combination of anatomical and functional testing. Non-invasive imaging like Coronary Computed Tomography Angiography (CCTA) allows for the direct visualization of plaque and luminal narrowing. A Coronary Artery Calcium (CAC) score of zero significantly reduces the likelihood of obstructive disease, while high scores indicate a high burden of ASHD. Stress echocardiography or myocardial perfusion imaging (MPI) can assess the functional impact of the plaques. In many cases, I25.10 is the diagnosis assigned after an invasive coronary angiogram shows disease but the patient reports no history of chest pain. ### Standard of Care Management is centered on secondary prevention to reduce the risk of acute coronary syndrome (ACS). The cornerstone of treatment is the 'ABCDE' approach: Aspirin and Antiplatelets, Blood pressure control, Cholesterol management (specifically high-intensity statins), Diet and Diabetes control, and Exercise and Education. Lifestyle changes are paramount, including a heart-healthy diet, weight loss if indicated, and absolute smoking cessation. Pharmacotherapy aims to stabilize existing plaques and prevent the formation of new ones. Prognosis depends on the extent of the disease, the presence of left ventricular dysfunction, and the patient's adherence to the intensive medical regimen.